Pedro José Romero Palacios

Pedro José Romero Palacios

Auto-generated profile, based on publicly available information

Pedro José Romero Palacios

Departamento de Medicina, Facultad de Medicina, Universidad de Granada, Granada, España

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2018 in European Respiratory Journal
Verified
Journal Article
Closed access
BABernardino Alcazar
Bernardino Alcazar
OROliverio Ruiz Rodríguez
Oliverio Ruiz Rodríguez
PBPablo Conde Baena
Pablo Conde Baena
PPPedro José Romero Palacios
Pedro José Romero Palacios
AAAlvar Agusti
Alvar Agusti
Preventing the occurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a major therapeutic goal. We hypothesise that persistently increased levels of exhaled nitric oxide (FeNO) during follow-up can identify a group of COPD patients at higher risk of AECOPD.To test this hypothesis, we measuredFeNOlevels (HypAirFeNO®, Medisoft; Sorinnes, Belgium) prospectively in 226 clinically stable COPD outpatients at recruitment and during follow-up (at 6 and 12 months). Patients were stratified according to the number of visits withFeNO≥20 ppb.FeNOwas <20 ppb in all three visits in 44.2% of patients, 29.6% in visit 1 and 26.1% in visit 2 or 3. These three groups suffered progressively higher AECOPD rates during follow-up (0.67, 0.91 and 1.42, respectively, p<0.001). After adjusting for potential confounding variables (log-rank test), the hazard ratio for AECOPD was higher in the latter group (1.579 (95% CI 1.049–2.378), p=0.029). Likewise, time to first moderate and severe AECOPD was shorter in these patients. Finally, there was no relationship betweenFeNOlevels and circulating eosinophils.PersistentFeNOlevels ≥20 ppb in clinically stable COPD outpatients are associated with a significantly higher risk of AECOPD.

1 April 2016 in Nitric Oxide
Verified
Journal Article
Closed access
BABernardino Alcazar
Bernardino Alcazar
PRP.J. Romero-Palacios
P.J. Romero-Palacios
ARA. Ruiz-Sancho
A. Ruiz-Sancho
ORO. Ruiz-Rodriguez
O. Ruiz-Rodriguez

1 July 2003 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
ACAntonio J Castro
Antonio J Castro
Juan De Dios AlcheJuan De Dios Alche
Juan De Dios Alche
Julián CuevasJulián Cuevas
Julián Cuevas
PRPedro José Romero
Pedro José Romero
VAVíctor Alché
Víctor Alché
MRMaría Isabel Rodríguez-García
María Isabel Rodríguez-García
Background: Commercial olive pollen from uncertain cultivar origin is the common material used for clinical and biological studies. We aimed to assess the putative heterogeneity of olive cultivars with regard to the presence of the major pollen allergen Ole e 1 and to determine whether these differences have clinical relevance. Methods: The Ole e 1 content of several cultivars was determined by immunoblotting and ultrastructural immunocytochemistry and compared to that of a commercially available olive pollen extract designed for diagnosis. Reverse transcription-polymerase chain reaction analysis of Ole e 1 transcripts was also performed. Crude protein extracts were used to carry out skin prick tests (SPTs) on 30 allergic patients in order to evaluate the clinical importance of such differences. Results: Ole e 1 was present in all cultivars, although significant quantitative differences were detected. Ole e 1 transcripts positively correlated with the amount of the allergen. Significant variations in the average reactivity of allergic patients to SPTs were observed depending on the cultivar considered. Conclusions: The presence of the Ole e 1 allergen in all the cultivars suggests that this allergen may play an essential biological role. The expression of the allergen is controlled at the transcriptional level. The significant differences in the Ole e 1 content are likely responsible for the different average reactivity exhibited by patients to the cultivars studied, although the role of other allergens cannot be excluded. Our results suggest that the use of the commercial pollen mixtures currently available may lead to mistakes in allergy diagnosis and to limited success in immunotherapy. Therefore, further standardization is strongly recommended.

1 March 2005 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
MBM. Barrueco
M. Barrueco
CRC. Jiménez Ruiz
C. Jiménez Ruiz
LPL. Palomo
L. Palomo
MTM. Torrecilla
M. Torrecilla
PRP. Romero
P. Romero
JRJ.A. Riesco
J.A. Riesco

6 November 2009 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
APAntonio Pereira-Vega
Antonio Pereira-Vega
JSJosé Luis Sánchez-Ramos
José Luis Sánchez-Ramos
JPJ. A. Maldonado Pérez
J. A. Maldonado Pérez
FAFrancisco Javier Alvarez-gutierrez
Francisco Javier Alvarez-gutierrez
JGJ. M. Ignacio García
J. M. Ignacio García
FMF. Gil Muñoz
F. Gil Muñoz
Our aim is to analyse the differences in the prevalence of premenstrual asthma (PMA) according to a set of criteria, the relationship between them and the influence of asthma severity.The answer “Yes” to “Does your asthma get worse before menstruation?” was considered subjective PMA. A daily respiratory symptoms register of fertile asthmatic females was taken during two consecutive menstrual cycles. For the semi-objective diagnosis, an exacerbation of ≥20% was required in the symptoms register. Objective diagnosis was a premenstrual worsening of ≥20% of peak flow.We selected 103 patients. Subjective premenstrual deterioration was perceived in 43.7%. The semi-objective deterioration of symptoms in the first cycle occurred in 44.7%, and in 22.3% in both cycles. A total of 54.3% of females with semi-objective criteria in the first cycle perceived a subjective deterioration of symptoms,versus35.1% of those without semi-objective criteria (p = 0.05). PMA was present at all levels of asthma severity, with no clear link to the degree of severity.The detection of PMA prevalence, the subjective perception of this deterioration and its presence at all levels of asthma severity lead us to urge research into possible premenstrual deterioration in all fertile asthmatic females.

1 April 2019 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
PRPedro J. Romero-Palacios
Pedro J. Romero-Palacios
BABernardino Alcazar
Bernardino Alcazar
JMJuan J. Díaz Mochón
Juan J. Díaz Mochón
Diego de Miguel-PerezDiego de Miguel-Perez
Diego de Miguel-Perez
JHJavier Luis Lopez Hidalgo
Javier Luis Lopez Hidalgo
MSMaría Jose Serrano
María Jose Serrano